The everyday tools for living well with T1D.

A dry-powder human insulin inhaled at the start of a meal. Its standout trait is speed — it reaches the blood and starts lowering glucose within minut

An ultra-long-acting basal insulin with a ~25-hour half-life and a flat, stable glucose-lowering effect lasting beyond 42 hours — its standout feature

A concentrated (300 U/mL) once-daily basal analog of insulin glargine. The triple concentration forms a smaller, more compact subcutaneous depot that

An investigational once-weekly basal insulin from Eli Lilly that fuses a single-chain insulin to an IgG Fc domain for a ~17-19 day half-life and a nea

The original once-daily, peakless basal analog and the affordable basal benchmark. A flat ~24-hour profile that transformed basal insulin, now with wi

Insulin lispro reformulated with treprostinil and citrate to widen and loosen local blood vessels, speeding absorption — one of the two fastest mealti

An ultra-rapid mealtime insulin — insulin aspart reformulated with niacinamide (and L-arginine) to speed early absorption, appearing in the blood abou

An investigational ultra-concentrated (500 U/mL), ultra-rapid mealtime insulin aspart from Arecor. In a Phase 1 type 1 diabetes clamp study it was abs

The long-standing rapid-acting mealtime analog and the practical reference point for "rapid insulin": approved since 1999–2000, pump-cleared, availabl

The original rapid-acting mealtime analog (1996) — the molecule that made fast, flexible bolus insulin possible. Decades of use, cleared for pumps, on

Arecor's U100 ultra-rapid insulin formulation, designed to accelerate absorption after injection or pump delivery and better match meal physiology. Ea

A rapid-acting mealtime analog, zinc-free so it stays largely un-clustered in the vial — giving it a marginally faster early action than aspart or lis

The first once-weekly basal insulin: a single injection covers seven days via an albumin-bound depot with a ~196-hour (≈8-day) half-life and a near-fl

An investigational mealtime insulin lispro from Diasome wrapped in a liver-targeting phospholipid carrier (HDV) that steers a fraction of each dose to

A class of insulins engineered to sense blood glucose and self-modulate their own activity — turning down when glucose is low to prevent hypoglycemia

The legacy intermediate-acting human (non-analog) basal insulin, and by far the cheapest and most accessible — sold behind the pharmacy counter withou